Immediate Impact

60 standout
Sub-graph 1 of 23

Citing Papers

Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
2025 Standout
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
2024 Standout
2 intermediate papers

Works of Marta Caporale being referenced

MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF -Mutated Colorectal Cancer
2016

Author Peers

Author Last Decade Papers Cites
Marta Caporale 248 144 112 114 16 415
Inge Ubink 235 83 142 131 19 440
Kouichiro Tsugawa 194 171 93 206 19 465
Jong Seok Lee 213 144 66 95 18 469
Giorgio Maria Verdecchia 166 111 101 216 22 482
Annelies Schnider 176 188 60 217 14 399
Alessio Pellegrinelli 356 92 51 77 23 506
D. Mari 246 143 67 187 14 390
Seong Woo Hong 227 121 86 81 26 441
Eiki Ojima 242 104 129 132 26 449
Edith Brutcher 364 128 26 153 20 482

All Works

Loading papers...

Rankless by CCL
2026